Drugs / GlyTI-M
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01725737 Comparator | Apr 2012 → Feb 2013 | attention deficit-hyperactivity disorder | Mackay Memorial Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GlyTI-M | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01725737 ↗ |
| Action | Inhibit | “GlyTI-M is an endogenous Glycine transporter I inhibitor” NCT01725737 ↗ |